<SEC-DOCUMENT>0001437749-26-013362-index.html : 20260427 <SEC-HEADER>0001437749-26-013362.hdr.sgml : 20260427 <ACCEPTANCE-DATETIME>20260427062113 ACCESSION NUMBER: 0001437749-26-013362 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 8 CONFORMED PERIOD OF REPORT: 20260430 FILED AS OF DATE: 20260427 DATE AS OF CHANGE: 20260427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALTERITY THERAPEUTICS LTD CENTRAL INDEX KEY: 0001131343 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: C3 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-49843 FILM NUMBER: 26896417 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: LEVEL 3, 460 BOURKE STREET CITY: MELBOURNE PROVINCE COUNTRY: C3 BUSINESS PHONE: 61 3 9349 4906 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: LEVEL 3, 460 BOURKE STREET CITY: MELBOURNE PROVINCE COUNTRY: C3 FORMER COMPANY: FORMER CONFORMED NAME: PRANA BIOTECHNOLOGY LTD DATE OF NAME CHANGE: 20010105 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>athe20260427_6k.htm <DESCRIPTION>FORM 6-K <TEXT> Document 1 - file: athe20260427_6k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>ex_951141.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 2 - file: ex_951141.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>page01.jpg <TEXT> Document 3 - file: page01.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>page02.jpg <TEXT> Document 4 - file: page02.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>page03.jpg <TEXT> Document 5 - file: page03.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>page04.jpg <TEXT> Document 6 - file: page04.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>page05.jpg <TEXT> Document 7 - file: page05.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>page06.jpg <TEXT> Document 8 - file: page06.jpg
</DOCUMENT> </SEC-DOCUMENT>